Oscar Health, Inc.
NYSE:OSCRMedical - Healthcare Plans
+$0.05 today
- Market cap
- $7.15B
- Beta
- 2.39
- P/E (TTM)
- -214.2
- EPS (TTM)
- -$0.13
Volume 7.38M
Average 7.51M
OSCR Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Oscar Health, Inc.NYSE: OSCR
Cash & Equivalents · Q2 FY2026 · quarter ended Jun 2026
Cash & equivalents rises 56.8% from a year ago
Cash & equivalents stood at $4.08B at the end of Q2 FY2026, up 56.8% from a year earlier and down 15.2% from the prior quarter. Over 3 fiscal years it compounded at +21.2% a year.
Context
- Cash & equivalents amounted to 36.3% of total assets at the end of Q2 FY2026, down 4.4 pp from a year earlier.
- Cash & equivalents increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +56.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 2.77B USD
- Year-over-year change
- +81.7%
- 4-year CAGR
- +25.9%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.77B | +81.7% |
| FY2024 | 2024-12-31 | 1.53B | -18.3% |
| FY2023 | 2023-12-31 | 1.87B | +20.0% |
| FY2022 | 2022-12-31 | 1.56B | +41.2% |
| FY2021 | 2021-12-31 | 1.1B | — |
Cash & Equivalents vs competitors
How OSCR compares with its peers on the latest reported figures
- OSCR's Jun 2026 cash & equivalents of $4.08B is the 6th highest of the 8 companies compared; the peer median is $6.19B.
- Its year-over-year change of +56.8% is the 3rd highest of 8, against a peer median of +6.1%.
- Cash & equivalents amounts to 36.3% of total assets for OSCR, versus a peer median of 27.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $24.15B | +66.4% | +14.0% | 29.1% | |
| Jun 2026 | $11.33B | -3.9% | -13.0% | 4.5% | |
| Sep 2026 | $10.35B | +18.8% | +8.7% | 8.1% | |
| Sep 2026 | $6.19B | +2.7% | +9.0% | 3.9% | |
| Sep 2026 | $4.48B | +6.1% | +2.0% | 28.6% | |
| Jun 2026 | $4.08B | +56.8% | +21.2% | 36.3% | |
| Mar 2026 | $1.41B | +216.3% | +12.2% | 111.9% | |
| Jun 2026 | $198.84M | +5.4% | -9.0% | 27.6% | |
| Peer median (excluding OSCR) | $6.19B | +6.1% | +8.7% | 27.6% | |
Competitors are the stored peer set for OSCR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 1.1B | 1.56B | 1.87B | 1.53B | 2.77B |
| Short-term Investments | 587.09M | 1.4B | 689.83M | 624.46M | 1.22B |
| Net Receivables | 1.04B | 1.16B | 494.39M | 315.89M | 442.65M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 28.09M | 27.48M | (982.95M) | 377.64M | 180.15M |
| Total Current Assets | 2.76B | 4.14B | 2.07B | 2.85B | 4.61B |
| Property, Plant & Equipment (Net) | 46.61M | 59.89M | 61.93M | 66.79M | 88.35M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 844.48M | 222.92M | 365.31M | 1.82B | 1.47B |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | (335.44M) | 101.21M | 1.1B | 113.28M | 152.67M |
| Total Non-current Assets | 555.65M | 384.01M | 1.53B | 2B | 1.71B |
| Total Assets | 3.32B | 4.53B | 3.6B | 4.84B | 6.33B |
| Account Payables | 718.81M | 1.37B | 1.03B | 1.4B | (99.75M) |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 75.04M | 79M | 0 | 0 | 0 |
| Other Current Liabilities | 29.25M | 4.21M | (2.26B) | 215.28M | 4.96B |
| Total Current Liabilities | 1.62B | 2.97B | (175.28M) | 3.17B | 4.86B |
| Long-term Debt | 0 | 298M | 298.78M | 299.56M | 430.1M |
| Deferred Tax Liabilities | 4.11M | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 311.63M | 370.12M | 2.67B | 61.28M | 51.99M |
| Total Non-current Liabilities | 315.74M | 668.12M | 2.97B | 360.84M | 482.09M |
| Total Liabilities | 1.93B | 3.63B | 2.8B | 3.82B | 5.34B |
| Common Stock | 2K | 2K | 2K | 2K | 3K |
| Retained Earnings | (2B) | (2.61B) | (2.88B) | (2.85B) | (3.29B) |
| Accumulated OCI | (3.67M) | (9.72M) | 1.31M | (1.83M) | 18.03M |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 5.29M | 2.02M | 2.15M | 2.84M | 3.09M |
| Total Equity | 1.39B | 892.4M | 806.12M | 1.02B | 980.74M |
| Total Debt | 0 | 298M | 298.78M | 299.56M | 430.1M |
| Net Debt | (1.1B) | (1.26B) | (1.57B) | (1.23B) | (2.34B) |
Oscar Health, Inc.
NYSE:OSCR
Intrinsic Alpha fair value
Locked
Current Price
$27.57
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.